Tumor cell expansion challenges current physics Blog Post

The journal Nature Physics published a study by a team led by Xavier Trepat, ICREA researcher at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park and lecturer at the Department of Biomedicine University of Barcelona (UB), and Jaume Casademunt, professor of Physics at the UB, reveals the forces these tumor cells use to spread. The relation between these forces and the cell movement goes beyond current physical laws. 

 

IBEC and IRB Barcelona are awarded funding from the Spanish Association Against Cancer Blog Post

Yesterday, coinciding with World Cancer Research Day (WCRD), which takes place on 24 September each year, theSpanish Association Against Cancer (Asociación Española Contra el Cáncer, AECC) celebrated the 2018 AECC Cancer Research Grants awards ceremony. Among the proposals selected are two projects from the Institute for Bioengineering of Catalonia (IBEC) and five from the Institute for Research in Biomedicine (IRB Barcelona), which is based at PCB.

 

The Barcelona Science Park is set to have a strong presence at BioSpain 2018 Blog Post

From 25 to 27 September, the FIBES Exhibition Congress Centre in Seville will be the venue for BioSpain 2018, one of the the largest biotech event in Europe and the fifth most important event in the world in terms of number of partnering meetings. This 9th edition of the event is being organised by the Spanish Bioindustry Association (ASEBIO) together with the Regional Government of Andalusia, through the IDEA Agency. Nearly one hundred companies and institutions from the BioRegion of Catalonia – including the Barcelona Science Park (PCB) and a large number of entities located in the Park – have confirmed their attendance at the fair, which is held every two years in a different Spanish city.

 

Barcelona Science Park celebrates 20 years as a scientific and business innovation centre Blog Post

Yesterday, Barcelona Science Park (Parc Científic de Barcelona, PCB) held the first of a number of events scheduled to commemorate its 20 years as a meeting place for universities, companies and society. Established by the University of Barcelona (UB) in 1997 with the mission of promoting formulas to enhance research excellence, knowledge transfer and entrepreneurship, it was the first science park in Spain. Twenty years after the first brick was laid, the Barcelona Science Park is now one of Europe’s leading science, technology and business innovation parks for life sciences. Covering an area of over 100,000 m2, it boasts a wide range of scientific and technological infrastructures and an innovative community made up of more than 100 public and private entities and 2,700 professionals

 

UTOX-PCB takes part in the Preclinonco project to develop innovative new cancer drugs Blog Post

The Unit of Experimental Toxicology and Ecotoxicology of the Barcelona Science Park (PCB) is taking part in a consortium that aims to develop and provide preclinical checks for new candidates for first-in-class cancer drugs. The project, called Preclinonco, has just received an injection of nearly 350,000 euros from the Retos-Colaboración 2017 program, promoted by the Ministry of Science, Innovation and Universities with ERDF funding.

 

The Barcelona Science Park announces a new artistic intervention competition Blog Post

The Barcelona Science Park (PCB) is holding a new artistic intervention competition which offers participants the chance to design, with total freedom, a 125 metre-long space in the Cluster building, one of the main communication channels between the various research laboratories of the PCB. The ‘L’aigua és vida‘ [Water is life] project, by painter Kelly Arrontes, won the previous competition in 2017.

 

IRB Barcelona has been awarded two ERC Proof of Concept to tackle colon cancer and cardiotoxicity Blog Post

Eduard Batlle and Angel R. Nebreda, ICREA researchers at the Institute for Research in Biomedicine (IRB Barcelona), have been awarded an ERC Proof of Concept grant. Over the next 18 months and supported by 150,000 euros of funding each, they will devote their efforts to developing tools with potential therapeutic applications in the field of oncology. This is the second time that these scientists have received an ERC PoC grant.

 

IBEC joins with Avinent to create prostheses that become real bone Blog Post

Advances in 3D bioprinted prostheses that are truly incorporated into the body –with their own blood vessels and sensitivity– are becoming increasingly more remarkable. This has been demonstrated by Avinent Implant System and the Biomaterials for Regenerative Therapies group led by Elisabeth Engell at the Institute for Bioengineering of Catalonia (IBEC), that are jointly developing an ambitious project to create 3D printed pieces from biomaterials.